Highest-materiality recent filing
Exelon Reports First Quarter 2026 Adjusted Earnings of $0.91 Per Share, Affirms Full-Year Guidance
GAAP net income of $0.90 per share and adjusted operating earnings of $0.91 per share for Q1 2026.
Exelon shareholders elect all 9 director nominees, ratify auditor, approve say-on-pay
All nine director nominees elected with 92.8% to 99.3% of votes cast, broker non-votes excluded.
Exelon subsidiary PECO withdraws rate case filings; Maryland utility regulation changes
PECO withdrew electric and gas rate filings with PA PUC, citing customer affordability; delays grid modernization investments.
Exelon issues $775M of 4.950% Notes due 2036 to refinance maturing 3.400% Notes
Issued $775M in 4.950% Notes due March 15, 2036; interest payable semi-annually.
Exelon Q4 adj EPS $0.59 vs $0.64 YoY; FY25 $2.77; FY26 guide $2.81-$2.91
Q4 2025 GAAP EPS $0.58, adj EPS $0.59; full-year adj EPS $2.77 ($2.50 YoY).
Exelon assigns David DeWalt to two board committees, effective April 27, 2026
David DeWalt appointed to Talent Management and Compensation Committee.
Exelon closes $1B of 3.25% convertible notes due 2029; net proceeds ~$987.5M
Issued $1B aggregate principal (incl. $100M over-allotment) of 3.25% convertible senior notes due March 15, 2029.
Exelon EVP Glockner to depart Jan 1, 2026; duties split between CFO and CLS
David Glockner, EVP Compliance, Audit and Risk, departs effective Jan 1, 2026; receives severance per existing plan.
Preliminary approval granted Nov 18, 2025 for consolidated derivative settlement related to ComEd bribery scheme.
Exelon announces ESP blackout period from Dec 3 to Dec 22, 2025
Blackout due to vendor change for Employee Savings Plan; starts Dec 3, 2025 at 4pm ET, ends week of Dec 22, 2025.
Exelon Q3 adjusted EPS $0.86, up from $0.71; reaffirms FY2025 guidance $2.64-$2.74
GAAP EPS $0.86, adjusted EPS $0.86 in Q3 2025 vs. $0.70/$0.71 year ago; net income $875M, up $168M.
Exelon Q2 adjusted EPS $0.39, down from $0.47 YoY; reaffirms FY guidance $2.64-2.74
GAAP net income $391M ($0.39/diluted) vs $448M ($0.45) in Q2 2024; adjusted operating earnings $392M ($0.39) vs $472M ($0.47).
Exelon shareholders elect all 9 director nominees, ratify PwC, approve say-on-pay
All nine director nominees elected with support ranging from 94.4% (Linda Jojo) to 99.7% (David DeWalt).
Exelon establishes $2.5B at-the-market equity offering program
May sell up to $2.5B aggregate gross sales price of common stock via sales agents and forward sellers.
Exelon Q1 adjusted EPS $0.92, reaffirms FY2025 guidance $2.64-$2.74
GAAP EPS $0.90, adjusted EPS $0.92 for Q1 2025, up from $0.66 and $0.68 YoY.
Exelon appoints David DeWalt to board of directors
David DeWalt appointed independent director effective March 10, 2025.
Exelon issues $1.0B in notes to repay $464M commercial paper; rates 5.125% (2031) and 5.875% (2055)
Issued $500M 5.125% notes due 2031 and $500M 5.875% notes due 2055.
Exelon closes $1B offering of 6.500% junior subordinated notes due 2055
Closed public offering of $1,000,000,000 aggregate principal of 6.500% Fixed-to-Fixed Reset Rate Junior Subordinated Notes due 2055.
Exelon Q4 adjusted EPS $0.64; initiates 2025 guidance $2.64-$2.74; raises 4-yr capex to $38B
Q4 2024 GAAP net income $0.64 per share; adjusted (non-GAAP) $0.64 per share, up from $0.60 in Q4 2023.
Exelon announces departure of Chief Legal Officer; Colette Honorable appointed successor
Gayle Littleton departs as EVP, Chief Legal Officer effective Jan 1, 2025; stays as Senior Advisor to CEO until Mar 31, 2025.
Exelon Q3 2024 adj EPS $0.71 vs $0.67; reaffirms FY2024 guidance $2.40-$2.50
GAAP net income $0.70/sh; adjusted operating EPS $0.71 (up from $0.67); FY2024 guidance reaffirmed at $2.40-$2.50; 5-7% EPS growth target through 2027 reaffirmed.
Exelon and subsidiaries enter $4.0B in amended revolving credit facilities
Exelon Corp. entered $900M five-year revolver with JPMorgan Chase Bank as administrative agent.
Exelon Q2 adjusted EPS $0.47 beats prior year; reaffirms FY2024 outlook
GAAP EPS $0.45; adjusted EPS $0.47 vs $0.41 in Q2 2023.
All director nominees elected with 94-99% for; John Young lowest at 94.28%.
Exelon Q1 adjusted EPS $0.68 vs $0.70 YoY; reaffirms FY guidance $2.40-$2.50
GAAP EPS $0.66 vs $0.67 Q1 2023; adjusted $0.68 vs $0.70; reaffirms full-year $2.40-$2.50 range.
On March 10, 2025, the Board of Directors ("Board") of Exelon Corporation (“Exelon”) appointed David DeWalt as an independent director of Exelon, effective immediately.
Max materiality 0.85 · Median 0.55 · Most common event earnings